p53 and E2f: partners in life and death - PubMed (original) (raw)
Review
doi: 10.1038/nrc2718.
Affiliations
- PMID: 19776743
- DOI: 10.1038/nrc2718
Review
p53 and E2f: partners in life and death
Shirley Polager et al. Nat Rev Cancer. 2009 Oct.
Abstract
During tumour development cells sustain mutations that disrupt normal mechanisms controlling proliferation. Remarkably, the Rb-E2f and MDM2-p53 pathways are both defective in most, if not all, human tumours, which underscores the crucial role of these pathways in regulating cell cycle progression and viability. A simple interpretation of the observation that both pathways are deregulated is that they function independently in the control of cell fate. However, a large body of evidence indicates that, in addition to their independent effects on cell fate, there is extensive crosstalk between these two pathways, and specifically between the transcription factors E2F1 and p53, which influences vital cellular decisions. This Review discusses the molecular mechanisms that underlie the intricate interactions between E2f and p53.
Similar articles
- E2F1-induced apoptosis: turning killers into therapeutics.
Stanelle J, Pützer BM. Stanelle J, et al. Trends Mol Med. 2006 Apr;12(4):177-85. doi: 10.1016/j.molmed.2006.02.002. Epub 2006 Mar 10. Trends Mol Med. 2006. PMID: 16530485 Review. - Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S, Bellamy CO, Dunbar DR, Harrison DJ, Prost S. Sheahan S, et al. BMC Cancer. 2007 Nov 19;7:215. doi: 10.1186/1471-2407-7-215. BMC Cancer. 2007. PMID: 18021445 Free PMC article. - E2F - at the crossroads of life and death.
Polager S, Ginsberg D. Polager S, et al. Trends Cell Biol. 2008 Nov;18(11):528-35. doi: 10.1016/j.tcb.2008.08.003. Epub 2008 Sep 18. Trends Cell Biol. 2008. PMID: 18805009 Review. - Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T, Pützer BM. Stiewe T, et al. Nat Genet. 2000 Dec;26(4):464-9. doi: 10.1038/82617. Nat Genet. 2000. PMID: 11101847 - Role for the p53 homologue p73 in E2F-1-induced apoptosis.
Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG Jr. Irwin M, et al. Nature. 2000 Oct 5;407(6804):645-8. doi: 10.1038/35036614. Nature. 2000. PMID: 11034215
Cited by
- Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways.
Huang S, Yan Q, Xiong S, Peng Y, Zhao R, Liu C. Huang S, et al. Biomed Res Int. 2020 Sep 28;2020:5425612. doi: 10.1155/2020/5425612. eCollection 2020. Biomed Res Int. 2020. PMID: 33062682 Free PMC article. - Carotid body growth during chronic postnatal hyperoxia.
Dmitrieff EF, Piro SE, Broge TA Jr, Dunmire KB, Bavis RW. Dmitrieff EF, et al. Respir Physiol Neurobiol. 2012 Mar 15;180(2-3):193-203. doi: 10.1016/j.resp.2011.11.006. Epub 2011 Nov 22. Respir Physiol Neurobiol. 2012. PMID: 22138179 Free PMC article. - MDMX elevation by a novel Mdmx-p53 interaction inhibitor mitigates neuronal damage after ischemic stroke.
Yan H, Sasaki T, Kanki H, Hirata Y, Nishiyama K, Hisada S, Matsumura S, Nagaoka Y, Sumiyoshi T, Nagano S, Nakata A, Yoshida M, Uesato S, Mochizuki H. Yan H, et al. Sci Rep. 2022 Dec 6;12(1):21110. doi: 10.1038/s41598-022-25427-4. Sci Rep. 2022. PMID: 36473920 Free PMC article. - LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53-Defective Cancer Cells.
La T, Chen S, Zhao XH, Zhou S, Xu R, Teng L, Zhang YY, Ye K, Xu L, Guo T, Jamaluddin MF, Feng YC, Tang HJ, Wang Y, Xu Q, Gu Y, Cao H, Liu T, Thorne RF, Shao FM, Zhang XD, Jin L. La T, et al. Adv Sci (Weinh). 2023 Mar;10(7):e2204599. doi: 10.1002/advs.202204599. Epub 2023 Jan 13. Adv Sci (Weinh). 2023. PMID: 36638271 Free PMC article. - MEF/ELF4 transactivation by E2F1 is inhibited by p53.
Taura M, Suico MA, Fukuda R, Koga T, Shuto T, Sato T, Morino-Koga S, Okada S, Kai H. Taura M, et al. Nucleic Acids Res. 2011 Jan;39(1):76-88. doi: 10.1093/nar/gkq762. Epub 2010 Aug 30. Nucleic Acids Res. 2011. PMID: 20805247 Free PMC article.
References
- Oncogene. 2000 May 11;19(20):2369-76 - PubMed
- Mol Cell Biol. 2002 Jan;22(1):370-7 - PubMed
- Mol Cell. 2001 Oct;8(4):781-94 - PubMed
- Nature. 1992 Mar 19;356(6366):215-21 - PubMed
- Genes Dev. 2001 Jul 15;15(14):1833-44 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous